The ARDSNet trial used an omega 3 and antioxidant supplement added to "usual" feeding (not any commercially available product). The study stopped for futility. "Futility" means there was no realistic chance that the intervention could be proven to be beneficial with the size trial we had planned. It would not be appropriate to make any conclusions about any other feeding product based upon our study, as it would also be inappropriate to conclude that our treatment was "harmful". The database for our study is not yet locked but once that is done we will be publishing our results which when viewed in their entirety may or may not influence your thinking about this topic.
Data from these two ARDSNet studies have been made available to the public. Go to the NHLBI web site (http://www.nhlbi.nih.gov/resources/deca/default.htm) for instructions on accessing these datasets.
Please see the attached listing of presentations/posters.
Hi! The website is back up. We've upgraded to Drupal 5.1. If you run into any problems, please let me know.
Ricky
Hi! The ARDSNet website will be down for a few hours tomorrow, Wed 2 May 2007, for an upgrade.
Hi! We've removed the ability for users to request new accounts through the website. If you want an account and are a member of the NHLBI ARDSNet, please contact the webmaster at ards-webmaster@hedwig.mgh.harvard.edu. Please make the subject be "ardsnet website account request". The NHLBI ARDSNet is a research network, and you must be a member of the network to receive an account.
Hi! As a part of the website upgrade, we decided to change how we were dealing with the publications to take advantage of some new capabilities of Drupal. This took a while to get in place, but the publications are now available! The new publications system has all kinds of cool abilities — click on "read more" to see a short list.
Limited access data sets are available for NHLBI studies supported by contract and for selected studies supported by cooperative agreements or other grants. The ARMA study falls under this policy.